ADA and systemic lupus erythematosus: Therefore, the aims of the present study were to elucidate the frequency of ADAs against RTX in two cohorts, one of SLE and one of AAV patients and, if ADA impact the intended pharmacodynamic effect of RTX in reducing the B cell count.